Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 6, 2020 - The FDA approved Mylan’s Hulio (adalimumab-fkjp), a biosimilar to AbbVie’s Humira® (adalimumab).
Download PDF
Return to publications
